bpc-157 danger BPC 157 Side Effects: What You Should Know BPC-157: Experimental Peptide Creates Risk

Muscle Regeneration: TB-500 drives muscle fiber repair

2-hypertonic flexor muscle, tail coiled and stiff

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

The few studies that exist are very small, low-quality, or were only tested on animals and cellsnot humans

also known as MAP3K7), p38 mitogen-activated protein kinase (p38 MAPK), RHO (RAS homolog)-like GTPase signaling pathways, phosphoinositide 3-kinase (PI3K)AKT (also known as protein kinase B), extracellular signal-regulated kinase (ERK), JUN N-terminal kinase (JNK) or nuclear factor-B (NF-B)

Competition for metabolic enzymes could theoretically alter the blood levels of either BPC-157 or the competing medication